Chen Xi, Yuan Yixiao, Zhou Fan, Li Lihua, Pu Jun, Zeng Yong, Jiang Xiulin
Key Laboratory of Neurological and Psychiatric Disease Research of Yunnan Province The Second Affiliated Hospital of Kunming Medical University Kunming China.
NHC Key Laboratory of Drug Addiction Medicine Kunming Medical University Kunming China.
MedComm (2020). 2025 May 29;6(6):e70226. doi: 10.1002/mco2.70226. eCollection 2025 Jun.
Lactylation, a recently identified post-translational modification, represents a groundbreaking addition to the epigenetic landscape, revealing its pivotal role in gene regulation and metabolic adaptation. Unlike traditional modifications, lactylation directly links metabolic intermediates, such as lactate, to protein function and cellular behavior. Emerging evidence highlights the critical involvement of lactylation in diverse biological processes, including immune response modulation, cellular differentiation, and tumor progression. However, its regulatory mechanisms, biological implications, and disease associations remain poorly understood. This review systematically explores the enzymatic and nonenzymatic mechanisms underlying protein lactylation, shedding light on the interplay between cellular metabolism and epigenetic control. We comprehensively analyze its biological functions in normal physiology, such as immune homeostasis and tissue repair, and its dysregulation in pathological contexts, including cancer, inflammation, and metabolic disorders. Moreover, we discuss advanced detection technologies and potential therapeutic interventions targeting lactylation pathways. By integrating these insights, this review aims to bridge critical knowledge gaps and propose future directions for research. Highlighting lactylation's multifaceted roles in health and disease, this review provides a timely resource for understanding its clinical implications, particularly as a novel target for precision medicine in metabolic and oncological therapies.
乳酰化是一种最近发现的翻译后修饰,是表观遗传领域的一项开创性补充,揭示了其在基因调控和代谢适应中的关键作用。与传统修饰不同,乳酰化直接将代谢中间体(如乳酸)与蛋白质功能和细胞行为联系起来。新出现的证据强调了乳酰化在多种生物过程中的关键参与,包括免疫反应调节、细胞分化和肿瘤进展。然而,其调控机制、生物学意义和疾病关联仍知之甚少。本综述系统地探讨了蛋白质乳酰化的酶促和非酶促机制,揭示了细胞代谢与表观遗传控制之间的相互作用。我们全面分析了其在正常生理过程中的生物学功能,如免疫稳态和组织修复,以及在病理情况下的失调,包括癌症、炎症和代谢紊乱。此外,我们还讨论了针对乳酰化途径的先进检测技术和潜在治疗干预措施。通过整合这些见解,本综述旨在弥合关键的知识差距,并提出未来的研究方向。本综述突出了乳酰化在健康和疾病中的多方面作用,为理解其临床意义提供了及时的资源,特别是作为代谢和肿瘤治疗中精准医学的一个新靶点。
MedComm (2020). 2025-5-29
Clin Sci (Lond). 2025-1-13
Front Genet. 2024-6-27
Drug Resist Updat. 2025-4-21
Clin Rev Allergy Immunol. 2025-3-13
Nat Immunol. 2024-11
J Cell Biol. 2024-11-4
Cancer Res. 2024-11-4